Details for New Drug Application (NDA): 040640
✉ Email this page to a colleague
NDA 040640 describes TRANYLCYPROMINE SULFATE, which is a drug marketed by Crossmedika Sa, Novitium Pharma, and Strides Pharma, and is included in three NDAs. It is available from three suppliers. Additional details are available on the TRANYLCYPROMINE SULFATE profile page.
The generic ingredient in TRANYLCYPROMINE SULFATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
The generic ingredient in TRANYLCYPROMINE SULFATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
Summary for 040640
| Tradename: | TRANYLCYPROMINE SULFATE |
| Applicant: | Strides Pharma |
| Ingredient: | tranylcypromine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 040640
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 040640
Suppliers and Packaging for NDA: 040640
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 040640 | ANDA | Strides Pharma Science Limited | 64380-176 | 64380-176-01 | 100 TABLET, FILM COATED in 1 BOTTLE (64380-176-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Jun 29, 2006 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
